Overview The Anti Angiogenic Ophthalmic Agent Market encompasses pharmaceuticals designed to inhibit abnormal blood vessel growth within the eye, primarily targeting conditions like age-related macular degeneration and diabetic retinopathy. These agents play a critical role in preserving vision by halting disease progression and reducing the need for invasive procedures. Their core functionalities include delivering targeted… Anti Angiogenic Ophthalmic Agent Market to Witness Huge Growth by 2033 weiterlesen